Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company's product pipeline... Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company's product pipeline includes pepinemab (VX15), which targets Huntington's Disease (HD) and non-small cell lung cancer (NSCLC) and also neurodegenerative disorders; VX5 Autoimmune for the treatment of MS and potentially for other autoimmune disorder; and others. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.149 | 0.149 | 0.149 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.149 | 0.149 | 0.149 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.149 | 0.149 | 0.149 | 0 | 0 | CS |
| 26 | -0.133 | -47.1631205674 | 0.282 | 0.31 | 0.148 | 154538 | 0.20616254 | CS |
| 52 | -0.3239 | -68.4922816663 | 0.4729 | 1.4099 | 0.148 | 2019102 | 0.91029074 | CS |
| 156 | -21.751 | -99.3196347032 | 21.9 | 25.5 | 0.148 | 9170365 | 2.05508794 | CS |
| 260 | -44.851 | -99.6688888889 | 45 | 149.8 | 0.148 | 6771075 | 2.48699287 | CS |
| Nessuna Discussione Trovata |
| Crea Discussione |
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
